FDA Inspection 1244660 - Gland Pharma Limited, Units I+II Pashamylaram Site - August 02, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Gland Pharma Limited, Units I+II Pashamylaram Site, with an inspection on August 2, 2024, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Gland Pharma Limited, Units I+II Pashamylaram Site
Inspection Date: August 2, 2024
Product Type: Human Drugs
Office: Office of Inspections and Investigations

Open in Dashboard

ID · 9a9126ce-3d6e-4ad7-891a-5cdd10d186bd

Violation Codes3

21 CFR 211.113(b)21 CFR 211.22(d)21 CFR 211.42(c)(10)(iv)

Full citation text and observation details available on the Dashboard.